Back to Trades
MURPHY ANDREW J
Co-Chief Scientific OfficerCIK 0001796226
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 43
- Companies
- 1
- Active
- 2025–2026
MURPHY ANDREW J, Co-Chief Scientific Officer, accounts for 5 disclosed filings worth $72.7M, all concentrated in REGENERON PHARMACEUTICALS, INC. (REGN), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $8.0M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Nov 18 | REGN REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | $4.8M |
| Nov 5 | REGN REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | Co-Chief Scientific Officer | Gift | $0 |
| Oct 15 | REGN REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | $3.2M |
| Dec 11 | REGN REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Tax withheld | $3.0M |
| Dec 9 | REGN REGENERON PHARMACEUTICALS, INC. | MURPHY ANDREW J | EVP Research | Grant | $14.5M |
5 filings